Al-Bitar Ahmad, Zahreddin Amnah, Shwin Mohammed, Barbar Abdullah, Dirani Alaa
Faculty of Medicine, Damascus University, Damascus, Syria.
Department of Surgery, Damascus Hospital, Damascus, Syria.
Case Rep Oncol. 2025 Feb 3;18(1):271-277. doi: 10.1159/000543952. eCollection 2025 Jan-Dec.
Primary breast lymphoma (PBL) is a rare non-Hodgkin lymphoma, predominantly presenting as diffuse large B-cell lymphoma (DLBCL) and primarily affecting the breast, often misdiagnosed due to its nonspecific symptoms resembling breast carcinoma. Breast implants are among the most frequently used medical devices for esthetic and reconstructive purposes.
We present a 24-year-old female with a growing breast mass who was diagnosed with PBL (non-Hodgkin's DLBCL). She underwent successful R-CHOP chemotherapy, resulting in complete remission. Follow-up imaging showed no distant metastasis or significant residual disease, with silicone implants intact and no pathological uptake.
PBL is a rare malignancy that primarily affects postmenopausal women, with diagnosis relying on radiologic investigations and histopathology due to its clinical and imaging similarities to breast carcinoma. Treatment is controversial and often involves rituximab-based chemotherapy, intrathecal methotrexate, and radiotherapy, with improved outcomes observed in recent years.
原发性乳腺淋巴瘤(PBL)是一种罕见的非霍奇金淋巴瘤,主要表现为弥漫性大B细胞淋巴瘤(DLBCL),主要累及乳腺,因其症状与乳腺癌相似且不具特异性,常被误诊。乳房植入物是最常用于美容和重建目的的医疗设备之一。
我们报告一名24岁女性,其乳腺肿物逐渐增大,被诊断为PBL(非霍奇金DLBCL)。她接受了成功的R-CHOP化疗,实现完全缓解。随访影像学检查显示无远处转移或明显残留病灶,硅胶植入物完好且无病理摄取。
PBL是一种罕见的恶性肿瘤,主要影响绝经后女性,由于其临床和影像学表现与乳腺癌相似,诊断依赖于放射学检查和组织病理学。治疗存在争议,通常包括基于利妥昔单抗的化疗、鞘内注射甲氨蝶呤和放疗,近年来疗效有所改善。